Literature DB >> 27296993

Differential Sex Response to Aspirin in Decreasing Aneurysm Rupture in Humans and Mice.

Nohra Chalouhi1, Robert M Starke1, Tatiana Correa1, Pascal M Jabbour1, Mario Zanaty1, Robert D Brown1, James C Torner1, David M Hasan2.   

Abstract

We previously found that aspirin decreases the risk of cerebral aneurysm rupture in humans. We aim to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin and confirm these observations in a mouse model of cerebral aneurysm. A nested case-control analysis from the International Study of Unruptured Intracranial Aneurysms was performed to assess whether a sex differential exists in the response of human cerebral aneurysms to aspirin. A series of experiments were subsequently performed in a mouse model of cerebral aneurysms. Aneurysms were induced with hypertension and elastase injection into mice basal cisterns. We found that aspirin decreased the risk of aneurysm rupture more significantly in men than in women in the International Study of Unruptured Intracranial Aneurysms. In mice, aspirin and cyclooxygenase-2 inhibitor did not affect cerebral aneurysm formation but significantly decreased the incidence of rupture. The incidence of rupture was significantly lower in male versus female mice on aspirin. Gene expression analysis from cerebral arteries showed higher 15-hydroxyprostaglandin dehydrogenase levels in male mice. The rate of cerebral aneurysm rupture was similar in male mice receiving aspirin and 15-hydroxyprostaglandin dehydrogenase inhibitor compared with females receiving aspirin and 15-hydroxyprostaglandin dehydrogenase agonist, signaling a reversal of the sex-differential response to aspirin. Aspirin decreases aneurysm rupture in human and mice, in part through cyclooxygenase-2 pathways. Evidence from animal and human studies suggests a consistent differential effect by sex. 15-Hydroxyprostaglandin dehydrogenase activation in females reduces the incidence of rupture and eliminates the sex-differential response to aspirin.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  aneurysm; aspirin; inflammation; sex; subarachnoid hemorrhage

Mesh:

Substances:

Year:  2016        PMID: 27296993      PMCID: PMC4945417          DOI: 10.1161/HYPERTENSIONAHA.116.07515

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  25 in total

1.  Aspirin for prophylaxis against cerebral aneurysm rupture.

Authors:  Nohra Chalouhi; Pascal Jabbour; Robert M Starke; David M Hasan
Journal:  World Neurosurg       Date:  2013-10-08       Impact factor: 2.104

Review 2.  Review of cerebral aneurysm formation, growth, and rupture.

Authors:  Nohra Chalouhi; Brian L Hoh; David Hasan
Journal:  Stroke       Date:  2013-10-15       Impact factor: 7.914

3.  Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.

Authors:  Jeffrey S Berger; Maria C Roncaglioni; Fausto Avanzini; Ierta Pangrazzi; Gianni Tognoni; David L Brown
Journal:  JAMA       Date:  2006-01-18       Impact factor: 56.272

4.  Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture.

Authors:  David M Hasan; Kelly B Mahaney; Robert D Brown; Irene Meissner; David G Piepgras; John Huston; Ana W Capuano; James C Torner
Journal:  Stroke       Date:  2011-10-06       Impact factor: 7.914

5.  Profile and prevalence of aspirin resistance in patients with cardiovascular disease.

Authors:  P A Gum; K Kottke-Marchant; E D Poggio; H Gurm; P A Welsh; L Brooks; S K Sapp; E J Topol
Journal:  Am J Cardiol       Date:  2001-08-01       Impact factor: 2.778

6.  Aspirin and aneurysmal subarachnoid hemorrhage.

Authors:  Bradley A Gross; Pui Man Rosalind Lai; Kai U Frerichs; Rose Du
Journal:  World Neurosurg       Date:  2013-03-30       Impact factor: 2.104

7.  Localized increase of chemokines in the lumen of human cerebral aneurysms.

Authors:  Nohra Chalouhi; Lauren Points; Gary L Pierce; Zuhair Ballas; Pascal Jabbour; David Hasan
Journal:  Stroke       Date:  2013-07-25       Impact factor: 7.914

Review 8.  Tumor necrosis factor-α modulates cerebral aneurysm formation and rupture.

Authors:  Robert M Starke; Daniel M S Raper; Dale Ding; Nohra Chalouhi; Gary K Owens; David M Hasan; Ricky Medel; Aaron S Dumont
Journal:  Transl Stroke Res       Date:  2013-09-20       Impact factor: 6.829

9.  Sex-related differences in the effects of aspirin on the interaction of platelets with subendothelium.

Authors:  G Escolar; E Bastida; M Garrido; J Rodríguez-Gómez; R Castillo; A Ordinas
Journal:  Thromb Res       Date:  1986-12-15       Impact factor: 3.944

10.  Critical role of TNF-α in cerebral aneurysm formation and progression to rupture.

Authors:  Robert M Starke; Nohra Chalouhi; Pascal M Jabbour; Stavropoula I Tjoumakaris; L Fernando Gonzalez; Robert H Rosenwasser; Kosuke Wada; Kenji Shimada; David M Hasan; Nigel H Greig; Gary K Owens; Aaron S Dumont
Journal:  J Neuroinflammation       Date:  2014-04-16       Impact factor: 8.322

View more
  12 in total

1.  Noninvasive Vagus Nerve Stimulation Prevents Ruptures and Improves Outcomes in a Model of Intracranial Aneurysm in Mice.

Authors:  Tomoaki Suzuki; Tsubasa Takizawa; Yoshinobu Kamio; Tao Qin; Tomoki Hashimoto; Yukihiko Fujii; Yuichi Murayama; Aman B Patel; Cenk Ayata
Journal:  Stroke       Date:  2019-05       Impact factor: 7.914

2.  Letter by Hasan et al Regarding Article, "Aspirin and Risk of Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis".

Authors:  David M Hasan; Emine Bayman; Joseph Broderick
Journal:  Stroke       Date:  2017-05-23       Impact factor: 7.914

3.  European Stroke Organisation (ESO) guidelines on management of unruptured intracranial aneurysms.

Authors:  Nima Etminan; Diana Aguiar de Sousa; Cindy Tiseo; Romain Bourcier; Hubert Desal; Anttii Lindgren; Timo Koivisto; David Netuka; Simone Peschillo; Sabrina Lémeret; Avtar Lal; Mervyn DI Vergouwen; Gabriel Je Rinkel
Journal:  Eur Stroke J       Date:  2022-06-03

4.  Decreased contrast enhancement on high-resolution vessel wall imaging of unruptured intracranial aneurysms in patients taking aspirin.

Authors:  Jorge A Roa; Mario Zanaty; Daizo Ishii; Yongjun Lu; David K Kung; Robert M Starke; James C Torner; Pascal M Jabbour; Edgar A Samaniego; David M Hasan
Journal:  J Neurosurg       Date:  2020-03-06       Impact factor: 5.115

5.  Mast Cell Promotes the Development of Intracranial Aneurysm Rupture.

Authors:  Hajime Furukawa; Kosuke Wada; Yoshiteru Tada; Atsushi Kuwabara; Hiroki Sato; Jinglu Ai; Michael T Lawton; Tomoki Hashimoto
Journal:  Stroke       Date:  2020-10-06       Impact factor: 7.914

6.  Sex Differential in 15-Hydroxyprostaglandin Dehydrogenase Levels in the Lumen of Human Intracranial Aneurysms.

Authors:  Nohra Chalouhi; Pascal Jabbour; Mario Zanaty; Robert M Starke; James Torner; Daichi Nakagawa; David M Hasan
Journal:  J Am Heart Assoc       Date:  2017-10-17       Impact factor: 5.501

7.  Genetic Risk Assessment of Elastin Gene Polymorphisms with Intracranial Aneurysm in Koreans.

Authors:  Jin Pyeong Jeon; Eun Pyo Hong; Jeong Eun Kim; Eun Jin Ha; Won-Sang Cho; Young-Je Son; Jae Seung Bang; Chang Wan Oh
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-11-10       Impact factor: 1.742

8.  Effect of combined acetylsalicylic acid and statins treatment on intracranial aneurysm rupture.

Authors:  Mikel Terceño; Sebastian Remollo; Yolanda Silva; Saima Bashir; Mariano Werner; Víctor A Vera-Monge; Joaquín Serena; Carlos Castaño
Journal:  PLoS One       Date:  2021-02-18       Impact factor: 3.240

Review 9.  Why Are Women Predisposed to Intracranial Aneurysm?

Authors:  Milène Fréneau; Céline Baron-Menguy; Anne-Clémence Vion; Gervaise Loirand
Journal:  Front Cardiovasc Med       Date:  2022-02-10

10.  Eicosapentaenoic acid prevents the progression of intracranial aneurysms in rats.

Authors:  Yu Abekura; Isao Ono; Akitsugu Kawashima; Katsumi Takizawa; Hirokazu Koseki; Haruka Miyata; Kampei Shimizu; Mieko Oka; Mika Kushamae; Susumu Miyamoto; Hiroharu Kataoka; Akira Ishii; Tomohiro Aoki
Journal:  J Neuroinflammation       Date:  2020-04-24       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.